Results 171 to 180 of about 14,643 (342)

Interobserver reproducibility of a hybrid three‐tier grading system of papillary nonmuscle invasive urothelial carcinoma: an international Uropathology study

Histopathology, EarlyView.
Hybrid grading of papillary nonmuscle invasive bladder cancer showed substantial agreement as assessed by interrater kappa values. This suggests that urologic pathologists can readily adapt to using a three‐tier hybrid grading system. Aims A hybrid‐three tier system with low grade (LG), high grade‐ G2 (HG‐G2), high grade‐ G3 (HG‐G3) has been proposed ...
Michelle R. Downes, Katherine Lajkosz, Ferran Algaba, Yves Allory, Mahul B. Amin, Liang Cheng, Sangeeta Desai, Markus Eckstein, Arndt Hartmann, Antonio Lopez‐Beltran, Sebastian Mannweiler, Maurits L. van Montfoort, Jon Oxley, Gladell P. Paner, Hemamali Samaratunga, Steven Shen, Joshua Warrick, Sean R. Williamson, Sara E. Wobker, Theodorus H. van der Kwast   +19 more
wiley   +1 more source

From Algorithms to Insight: The Transformative Power of Artificial Intelligence and Machine Learning in Urological Cancer Research. [PDF]

Curr Oncol
May M, Brookman-May S, Rinderknecht E.
europepmc   +1 more source

Assessment and classification of sex cord‐stromal tumours of the testis: recommendations from the testicular sex cord‐stromal tumour (TESST) group, an Expert Panel of the Genitourinary Pathology Society (GUPS) and International Society of Urological Pathology (ISUP)

Histopathology, EarlyView.
FH immunohistochemistry is recommended in clinically malignant Leydig cell tumours and in primary Leydig cell tumours with aggressive histopathologic features. Aims Testicular sex cord‐stromal tumours (TSCSTs) are relatively rare, accounting for ~5% of all testicular neoplasms.
Andres M Acosta, Maurizio Colecchia, Eva Comperat, Kristine M Cornejo, Anthony J Gill, Sounak Gupta, John C Cheville, Muhammad T Idrees, Chia‐Sui Kao, Fiona Maclean, Andres Matoso, Maria Rosaria Raspollini, Kvetoslava Michalova, Miguel Reyes Mugica, Satish K Tickoo, Toyonori Tsuzuki, Thomas M Ulbright, Sean R Williamson, Stephanie Siegmund, Lynette M Sholl, Pilar Gonzalez‐Peramato, Daniel M Berney   +21 more
wiley   +1 more source

Hot Spots in Urogenital Basic Cancer Research and Clinics. [PDF]

Cancers (Basel)
Manini C, Larrinaga G, Angulo JC, López JI.   +3 more
europepmc   +1 more source

The Effectiveness and Safety Profile of Nivolumab‐Plus‐Ipilimumab in Previously Untreated Japanese Patients With Advanced or Metastatic Renal Cell Carcinoma (J‐ENCORE Study)

International Journal of Urology, EarlyView.
ABSTRACT Objectives Combination therapy of nivolumab‐plus‐ipilimumab has been approved for advanced or metastatic renal cell carcinoma in Japan, but large‐scale clinical data targeting Japanese patients is limited. To evaluate the early outcomes and factors related to early progression and response.
Koshiro Nishimoto, Go Kimura, Tomokazu Sazuka, Shuzo Hamamoto, Masahiro Nozawa, Kazuyuki Numakura, Atsushi Mizokami, Tsunenori Kondo, Sei Naito, Takashige Abe, Kojiro Ohba, Masayoshi Nagata, Shunta Onodera, Hiroaki Ito, Hirotsugu Uemura   +14 more
wiley   +1 more source

Serum Matrix Metalloproteinases and Risk of Urologic Cancers: A Bidirectional Mendelian Randomization Study. [PDF]

Am J Mens Health
Yang B, Zeng X, Wang H, Feng J, Hou S.
europepmc   +1 more source

The effects of the current World Health Organization/International Society of Urologic Pathologists bladder neoplasm classification system on urine cytology results

, 2002
Jonathan L. Curry, Eva M. Wojcik
openalex   +1 more source

Validation of preoperative variables and stratification of patients to help predict benefit of cytoreductive nephrectomy in the targeted therapy ERA [PDF]

, 2017
Kim, Eric H, Manley, Brandon J, Potretzke, Aaron M, Strope, Seth A, Vetter, Joel M   +4 more
core   +2 more sources

Survivorship Post‐Retroperitoneal Lymph Node Dissection for Metastatic Testicular Cancer: A Systematic Review

International Journal of Urology, EarlyView.
ABSTRACT Introduction Retroperitoneal lymph node dissection (RPLND) may be considered after chemotherapy or as primary treatment in patients with metastatic testicular cancer. We aimed to perform a systematic review to analyze outcomes in survivors across the domains of sexual, physical, and psychological function.
Gavin G. Calpin, Niall J. O'Sullivan, Cian Hehir, Arun Z. Thomas, Rowan G. Casey   +4 more
wiley   +1 more source

Changes in urologic research from a new perspective: Text mining analysis of publication topics. [PDF]

Investig Clin Urol
Joo S, Lu K, Park J, Rho MJ, Park YH.
europepmc   +1 more source